Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ariela Noy

Showing results (31-40 of 138) with videos related to

Pageof 14
Sort By:
Leukemia & Lymphoma|May 17, 2017
High frequency of identical clonal immunoglobulin DNA in pre-treatment tumor and plasma from untreated patients with HIV-associated lymphoma: prospective multicenter trial of the AIDS malignancies consortium (AMC 064)Nina D Wagner-Johnston, Shelly Lensing, Ariela Noy, et al.
Cancer Journal (Sudbury, Mass.)|November 6, 2002
Rituximab for aggressive non-Hodgkin's lymphomas relapsing after or refractory to autologous stem cell transplantationDorothy Pan, Craig H Moskowitz, Andrew D Zelenetz, et al.
Plos One|February 11, 2009
Human T cell leukemia virus reactivation with progression of adult T-cell leukemia-lymphomaLee Ratner, William Harrington, Xuan Feng, et al.
Journal of Cancer Epidemiology|November 25, 2016
Risk of Cancer among Commercially Insured HIV-Infected Adults on Antiretroviral TherapyJeannette Y Lee, Ishwori Dhakal, Corey Casper, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 18, 2020
Phase 2 Study of Iodine-131 Tositumomab Plus Chemotherapy in Patients With Previously Untreated Mantle-Cell LymphomaAndrew D Zelenetz, Leslie L Popplewell, Ariela Noy, et al.
AIDS (London, England)|December 28, 2017
Brentuximab vedotin with AVD shows safety, in the absence of strong CYP3A4 inhibitors, in newly diagnosed HIV-associated Hodgkin lymphomaPaul G Rubinstein, Page C Moore, Michelle A Rudek, et al.
Cancer|September 16, 2003
Intensive chemotherapy with cyclophosphamide, doxorubicin, high-dose methotrexate/ifosfamide, etoposide, and high-dose cytarabine (CODOX-M/IVAC) for human immunodeficiency virus-associated Burkitt lymphomaEunice S Wang, David J Straus, Julie Teruya-Feldstein, et al.
British Journal of Haematology|June 8, 2004
Adverse prognostic significance of CD20 positive Reed-Sternberg cells in classical Hodgkin's diseaseCarol S Portlock, Gerard B Donnelly, Jing Qin, et al.
Cancers|January 28, 2026
Phase I Study of Mogamulizumab in Combination with Pembrolizumab in Patients with Relapsed or Refractory Non-Hodgkin Lymphoma-A National Cancer Institute Experimental Therapeutics Clinical Trials Network (NCI-ETCTN) TrialErel Joffe, Anita Kumar, Joseph M Tuscano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 16, 2009
Immunophenotypic analysis of AIDS-related diffuse large B-cell lymphoma and clinical implications in patients from AIDS Malignancies Consortium clinical trials 010 and 034Amy Chadburn, April Chiu, Jeannette Y Lee, et al.
Pageof 14

Showing results (31-40 of 138) with videos related to

Sort By:
Pageof 14
Leukemia & Lymphoma|May 17, 2017
High frequency of identical clonal immunoglobulin DNA in pre-treatment tumor and plasma from untreated patients with HIV-associated lymphoma: prospective multicenter trial of the AIDS malignancies consortium (AMC 064)Nina D Wagner-Johnston, Shelly Lensing, Ariela Noy, et al.
Cancer Journal (Sudbury, Mass.)|November 6, 2002
Rituximab for aggressive non-Hodgkin's lymphomas relapsing after or refractory to autologous stem cell transplantationDorothy Pan, Craig H Moskowitz, Andrew D Zelenetz, et al.
Plos One|February 11, 2009
Human T cell leukemia virus reactivation with progression of adult T-cell leukemia-lymphomaLee Ratner, William Harrington, Xuan Feng, et al.
Journal of Cancer Epidemiology|November 25, 2016
Risk of Cancer among Commercially Insured HIV-Infected Adults on Antiretroviral TherapyJeannette Y Lee, Ishwori Dhakal, Corey Casper, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 18, 2020
Phase 2 Study of Iodine-131 Tositumomab Plus Chemotherapy in Patients With Previously Untreated Mantle-Cell LymphomaAndrew D Zelenetz, Leslie L Popplewell, Ariela Noy, et al.
AIDS (London, England)|December 28, 2017
Brentuximab vedotin with AVD shows safety, in the absence of strong CYP3A4 inhibitors, in newly diagnosed HIV-associated Hodgkin lymphomaPaul G Rubinstein, Page C Moore, Michelle A Rudek, et al.
Cancer|September 16, 2003
Intensive chemotherapy with cyclophosphamide, doxorubicin, high-dose methotrexate/ifosfamide, etoposide, and high-dose cytarabine (CODOX-M/IVAC) for human immunodeficiency virus-associated Burkitt lymphomaEunice S Wang, David J Straus, Julie Teruya-Feldstein, et al.
British Journal of Haematology|June 8, 2004
Adverse prognostic significance of CD20 positive Reed-Sternberg cells in classical Hodgkin's diseaseCarol S Portlock, Gerard B Donnelly, Jing Qin, et al.
Cancers|January 28, 2026
Phase I Study of Mogamulizumab in Combination with Pembrolizumab in Patients with Relapsed or Refractory Non-Hodgkin Lymphoma-A National Cancer Institute Experimental Therapeutics Clinical Trials Network (NCI-ETCTN) TrialErel Joffe, Anita Kumar, Joseph M Tuscano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 16, 2009
Immunophenotypic analysis of AIDS-related diffuse large B-cell lymphoma and clinical implications in patients from AIDS Malignancies Consortium clinical trials 010 and 034Amy Chadburn, April Chiu, Jeannette Y Lee, et al.
Pageof 14